The Specialized Donor Care Facility (SDCF) Model and Advances in Management of Thoracic Organ Donors.

Abstract Background Donor hearts and lungs are more susceptible to the inflammatory physiologic changes that occur after brain death. Prior investigations have shown that protocolized management of potential organ donors can rehabilitate donor organs that are initially deemed unacceptable. In this review, we discuss advances in donor management models with particular attention to the specialized donor care facility (SDCF) model. In addition, we review specific strategies to optimize donor thoracic organs and improve organ yield in thoracic transplantation. Methods We performed a literature review by searching the Pubmed database for MeSH terms associated with organ donor management models. We also communicated with our local organ procurement organization to gather published and unpublished information first-hand. Results The SDCF model has been shown to improve the efficiency of organ donor management and procurement while reducing costs and minimizing travel and its associated risks. Lung protective ventilation, recruitment of atelectatic lung, and hormone therapy (e.g., glucocorticoids and T3/T4) are associated with improved lung utilization rates. Stroke volume-based volume resuscitation is associated with improved heart utilization rates, while studies evaluating hormone therapy (e.g., glucocorticoids and T3/T4) have shown variable results. Conclusions Lack of high-quality prospective evidence results in conflicting practices across organ procurement organizations and best practices remain controversial. Future studies should focus on prospective, randomized investigations to evaluate donor management strategies. The SDCF model fosters a collaborative environment that encourages academic inquiry and is an ideal setting for these investigations.